Extension of provision of Seegene rapid in-house SARS CoV 2 Testing System

GoodsAward procedure without prior publication of a call for competition

Awarded value£300,000published contract · exc. VAT

Awarded 25 Jan 2023no call for competition

Awarded to Accuscience Limited2 awards

What is being bought

Published requirement description

Procurement to extend provision of Seegene rapid in-house SARS CoV 2 Testing System

CPV: Laboratory, optical and precision equipments (excl. glasses)

single lot · no lot value published

Lot #1Awarded

Delivery: Northern Ireland · Belfast Health and Social Care Trust

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 22 Nov 2022, 14:11 GMT
Last source update: 6 Feb 2023, 14:15 GMT
Authority reference: DAC10952
FTS notice number: 2023/S 000-003588
Classification (CPV): Laboratory, optical and precision equipments (excl. glasses)
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-03874d Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons; Additional deliveries by the original supplier ordered under the strict conditions stated in the directive
Published justification: No reasonable alternative exists for this procurement, it is in the public interest and is required to enable the Regional Virology Laboratory to meet Covid-19 surge testing requirements. A change of supplier would oblige the contracting authority to acquire supplies having different technical characteristics which would result in incompatibility or disproportionate technical difficulties in operation and maintenance that would impact service delivery and patient care.
The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Published awards, contracts and bid statistics, not a forecast

Awards 2

Awarded value £300,0001 contract exc. VAT · 1 repeated publication of the same award counted once

Bids received 1

Contracts signed 2latest 25 Jan 2023

Awarded to	Value	Date	Status
Accuscience Limited	£300,000 †same award published again · counted once	—	Awarded
Accuscience Limited	£300,000 †	—	Awarded

Contracts

Procurement to extend provision of Seegene rapid in-house SARS CoV 2 Testing System · Accuscience Limited
Signed
25 Jan 2023
Value
£300,000
Status
active
Procurement to extend provision of Seegene rapid in-house SARS CoV 2 Testing System · Accuscience Limited
Signed
22 Nov 2022
Value
£300,000
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authorityCentral GovernmentBody governed by public lawHealth LISBURN ROAD, BELFAST, Northern Ireland, BT97ABContact name, email

1 commercial party on the notice

Accuscience LimitedAwarded supplier Unit 3, M7 Business Park, Naas, IE, W91 XF79

Official links; attachments are not copied

No document links were published on the notice.